English research spending will remain stable in 2015 and 2016; however, universities will face cuts. According to the Department for Business, Innovation and Skills’ (BIS) February grant letter to the Higher Education Funding Council for England, university funding will decline from £4.1 billion ($6.8 billion) in 2015 to £4.0 billion in 2016. Core funding for […]
In 2005, the NIH initiated the $376 million Cancer Genome Atlas (TCGA) that has successfully identified new cancer genes from 500 samples from more than 20 cancer types. As the project nears its close, investigators are faced with deciding in which direction to proceed. A study by scientists at the Broad Institute of MIT and […]
Over the next five years, Saudi Arabia is planning to have 100,000 genomes sequenced to gain a better understanding of the diseases of genetic origin or influence among the kingdom’s population. Approximately 8% of Saudi children are born with acute genetic disorders, and over 30% of adults have type 2 diabetes (T2D). The proportion of […]
In 2013, the FDA’s Center for Drug Evaluation and Research approved 25 small molecular drugs and 2 biologic drugs, compared to 33 and 6, respectively, in 2012. Nine orphan new medical entities (NMEs) were approved, as were 8 cancer drugs, of which 6 were orphan NMEs. In addition, companion diagnostics information was provided for 3 […]
The passage this month of the Agricultural Act of 2014, or Farm Bill, provides $512 million for scientific research over five years. Funding each year will be 3.8% less than the previous Farm Bill. However, the legislation provides mandatory funding, which will not require approval by Congress each year. The Bill increases funding for organic […]
With only nine of the 16 companies in the IBO Laboratory Instrument Index reporting quarterly results before this issue’s publication, IBO estimates fourth quarter 2013 sales improved roughly 7%, or 6% excluding currency. The jump in growth was a result of strong results from Illumina and Waters, as well as the combined Agilent Technologies Life […]
Hillsboro, OR 2/5/14—FEI has acquired Lithicon, a provider of digital rock technology services and pore-scale micro–computed tomography (microCT) equipment to oil and gas companies, for $68 million. In addition, through a licensing and development agreement, FEI has acquired the helical scan microCT product and associated software from Australian National University. “The acquisition of Lithicon and […]
Waltham, MA 2/3/14—Thermo Fisher Scientific has completed its $15.1 billion acquisition of Life Technologies (see IBO 4/15/13). The purchase price consisted of $76.13 in cash per fully diluted common share, or approximately $13.6 billion, and the assumption of $1.5 billion in net debt. “Our combined offering provides cutting edge technologies, such as genomics and proteomics, […]
Radnor, PA 2/3/14—VWR International has agreed to acquire Germany-based Peqlab Biotechnologie for an undisclosed amount. Peqlab has subsidiaries and operations in the US, UK and Austria and also owns the Clemens manufacturing operation in Germany. Peqlab develops, manufactures and supplies molecular and cell biology reagents, consumables and instruments to support the education, research, health care […]
With the capability of measuring physical, mechanical, electrical and other properties with nanometer resolution, atomic force microscopy (AFM) is a versatile technique. The advent of AFM-Raman spectroscopy in the late 1990s added to this versatility, enabling the addition of chemical information, including molecular orientation in polymers. Since that time, demand for the technique has grown […]
Pay Invoice
Latest Blogs
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
-
Survey Results: Life Science Labs and Sustainable Consumables
August 30, 2024 7:43 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
